Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:1769-1776
Published online before print March 12, 2007, doi: 10.1161/CIRCULATIONAHA.106.652016
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
115/13/1769    most recent
CIRCULATIONAHA.106.652016v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jahnke, C.
Right arrow Articles by Paetsch, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jahnke, C.
Right arrow Articles by Paetsch, I.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*MRI Scans
Related Collections
Right arrow CT and MRI
Right arrow Chronic ischemic heart disease

(Circulation. 2007;115:1769-1776.)
© 2007 American Heart Association, Inc.


Imaging

Prognostic Value of Cardiac Magnetic Resonance Stress Tests

Adenosine Stress Perfusion and Dobutamine Stress Wall Motion Imaging

Cosima Jahnke, MD; Eike Nagel, MD; Rolf Gebker, MD; Thomas Kokocinski, MD; Sebastian Kelle, MD; Robert Manka, MD; Eckart Fleck, MD; Ingo Paetsch, MD

From the Department of Internal Medicine/Cardiology, German Heart Institute, Berlin, Germany.

Correspondence to Ingo Paetsch, MD, Internal Medicine/Cardiology, German Heart Institute Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. E-mail paetsch{at}dhzb.de

Received July 14, 2006; accepted February 1, 2007.

Background— Adenosine stress magnetic resonance perfusion (MRP) and dobutamine stress magnetic resonance (DSMR) wall motion analyses are highly accurate for the detection of myocardial ischemia. However, knowledge about the prognostic value of stress MR examinations is limited. We sought to determine the value of MRP and DSMR, as assessed during a single-session examination, in predicting the outcome of patients with known or suspected coronary artery disease.

Methods and Results— In 513 patients (with known or suspected coronary disease, prior coronary artery bypass graft, or percutaneous coronary intervention), a combined single-session magnetic resonance stress examination (MRP and DSMR) was performed at 1.5 T. For first-pass perfusion imaging, the standard adenosine stress imaging protocol (140 µg · kg–1 · min–1 for 6 minutes, 3-slice turbo field echo–echo-planar imaging or steady-state free precession sequence, 0.05 mmol/kg Gd-DTPA) was applied, and for DSMR, the standard high-dose dobutamine/atropine protocol (steady-state free-precession cine sequence) was applied. Stress testing was classified as pathological if at MRP ≥1 segment showed an inducible perfusion deficit >25% transmurality or if at DSMR ≥1 segment showed an inducible wall motion abnormality. During a median follow-up of 2.3 years (range, 0.06 to 4.55 years), 19 cardiac events occurred (4.1%; 9 cardiac deaths, 10 nonfatal myocardial infarctions). The 3-year event-free survival was 99.2% for patients with normal MRP and DSMR and 83.5% for those with abnormal MRP and DSMR. Univariate analysis showed ischemia identified by MRP and DSMR to be predictive of cardiac events (hazard ratio, 12.51; 95% confidence interval, 3.64 to 43.03; and hazard ratio, 5.42; 95% confidence interval, 2.18 to 13.50; P<0.001, respectively); other predictors were diabetes mellitus, known coronary artery disease, and the presence of resting wall motion abnormality. By multivariate analysis, ischemia on magnetic resonance stress testing (MRP or DSMR) was an independent predictor of cardiac events. In a stepwise multivariate model (Cox regression), an abnormal magnetic resonance stress test result had significant incremental value over clinical risk factors and resting wall motion abnormality (P<0.001).

Conclusions— In patients with known or suspected coronary artery disease, myocardial ischemia detected by MRP and DSMR can be used to identify patients at high risk for subsequent cardiac death or nonfatal myocardial infarction. For patients with normal MRP and DSMR, the 3-year event-free survival was 99.2%. MR stress testing provides important incremental information over clinical risk factors and resting wall motion abnormalities.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
JNMHome page
P. G. Camici and O. E. Rimoldi
The Clinical Value of Myocardial Blood Flow Measurement
J. Nucl. Med., July 1, 2009; 50(7): 1076 - 1087.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
D. C. Lee and N. P. Johnson
Quantification of Absolute Myocardial Blood Flow by Magnetic Resonance Perfusion Imaging
J. Am. Coll. Cardiol. Img., June 1, 2009; 2(6): 761 - 770.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
E. Nagel, J. A.C. Lima, R. T. George, and C. M. Kramer
Newer methods for noninvasive assessment of myocardial perfusion cardiac magnetic resonance or cardiac computed tomography?
J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 656 - 660.
[Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
A. S. Flett, M. A. Westwood, L. C. Davies, A. Mathur, and J. C. Moon
The Prognostic Implications of Cardiovascular Magnetic Resonance
Circ Cardiovasc Imaging, May 1, 2009; 2(3): 243 - 250.
[Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
M. Hadamitzky, B. Freissmuth, T. Meyer, F. Hein, A. Kastrati, S. Martinoff, A. Schomig, and J. Hausleiter
Prognostic Value of Coronary Computed Tomographic Angiography for Prediction of Cardiac Events in Patients With Suspected Coronary Artery Disease
J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 404 - 411.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
E. Nagel
Taking the Last Hurdles: Magnetic Resonance Myocardial Perfusion Imaging
J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 434 - 436.
[Full Text] [PDF]


Home page
Heart AsiaHome page
F Alpendurada, J Wong, and D J Pennell
Practical applications of cardiovascular magnetic resonance
Heart Asia, March 31, 2009; 2009(3): 16 - 22.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Lockie, E. Nagel, S. Redwood, and S. Plein
Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes
Circulation, March 31, 2009; 119(12): 1671 - 1681.
[Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
E. L. Wallace, T. M. Morgan, T. F. Walsh, E. Dall'Armellina, W. Ntim, C. A. Hamilton, and W. G. Hundley
Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease.
J. Am. Coll. Cardiol. Img., March 1, 2009; 2(3): 299 - 307.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
G. Korosoglou, D. Lossnitzer, D. Schellberg, A. Lewien, A. Wochele, T. Schaeufele, M. Neizel, H. Steen, E. Giannitsis, H. A. Katus, et al.
Strain-Encoded Cardiac MRI as an Adjunct for Dobutamine Stress Testing: Incremental Value to Conventional Wall Motion Analysis
Circ Cardiovasc Imaging, March 1, 2009; 2(2): 132 - 140.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The Year in Cardiac Imaging
J. Am. Coll. Cardiol., September 4, 2007; 50(10): 988 - 1003.
[Full Text] [PDF]